Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells

Prostate Cancer Cell-Derived Urokinase-Type Plasminogen Activator Contributes to Intraosseous Tumor Growth and Bone Turnover

(2015) Zhong Dong et al.   NEOPLASIA

Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF

(2014) Nobuto Yamamoto et al.   Translational Oncology

Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity

(2009) Marilena Greco et al.   CANCER LETTERS

CCR3 is a target for age-related macular degeneration diagnosis and therapy

(2009) Atsunobu Takeda et al.   NATURE

Evolving role of uPA/uPAR system in human cancers

(2008) Kathleen Dass et al.   CANCER TREATMENT REVIEWS

Retracted: Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF)

(2008) Nobuto Yamamoto et al.   JOURNAL OF MEDICAL VIROLOGY

Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression

(2008) S Serratì et al.   JOURNAL OF PATHOLOGY

Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: Potential for regulation of tumor growth

(2007) Michael Fannon et al.   JOURNAL OF CELLULAR PHYSIOLOGY